It has no growth.
Stock price when the opinion was issued
Spun off from Merck two years, but has been sitting in the penalty box. Pays a 5.5% dividend at 5x earnings.
Recently on a downward trend. Fundamentally scores 3/10. Would not recommend buying. Price target falling. Has not been able to beat earnings. Better options available for investors. High debt levels not good for dividend outlook.
Build our watch list
Sign in to track investmentsyou care about
5i Research
CNBC
iA Global Asset Management
Kingwest & Company
Stockchase Premium
It has no growth.